Positioning Part D Drug Plans For Success Under The IRA

The industry is still a few years away from knowing the full impact that the Inflation Reduction Act will have on drug prices. But some critical provisions already impacted drug plan sponsors for 2024 and will shape decision-making for 2025.

Beginning in 2024, Part D plan sponsors must reimburse pharmacies based on the lowest available price at the point of sale, effectively eliminating the common practice of payers reducing pharmacy payments through post-point-of-sale direct and indirect remuneration. We analyzed Centers for Medicare...